| |
MVS group (n = 20)
|
PMVR group (n = 23)
|
OPCAB group (n = 25)
|
|---|
|
pre
|
post
|
p-value
|
pre
|
post
|
p-value
|
pre
|
post
|
p-value
|
|---|
|
RVEF, %
|
37 ± 13
|
32 ± 9
|
0.15
|
30 ± 10
|
29 ± 10
|
0.85
|
38 ± 10
|
35 ± 7
|
0.12
|
|
TAPSE, mm
|
13.1 ± 5.1
|
11.0 ± 3.5
|
0.04*
|
10.6 ± 3.4
|
11.0 ± 4.4
|
0.69
|
10.6 ± 3.4
|
11 ± 3.7
|
0.96
|
|
FWLS, %
|
− 20.1 ± 7.1
|
−15.4 ± 5.1
|
< 0.001***
|
−17.9 ± 4.9
|
−16.4 ± 6.2
|
0.28
|
− 19.6 ± 6.9
|
- 17.2 ± 6.0
|
0.06
|
|
RVEFlong, %
|
20 ± 5
|
13 ± 6
|
< 0.001***
|
12 ± 5
|
12 ± 5
|
0.50
|
18 ± 7
|
14 ± 5
|
< 0.01**
|
- FWLS free wall longitudinal strain, RVEF right ventricular ejection fraction, RVEFlong longitudinal contribution to right ventricular ejection fraction, TAPSE tricuspid annular plane systolic excursion
